Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 33 for “"PDE3"”.
-
Exploring the Molecular Pathways of Cell Death Induced by PDE3 Modulators
… LKB1 suppresses phosphodiesterases (PDEs), and PDE3 modulators can selectively eradicate LKB1-deficient tumor cells. Through metabolic gene sgRNA library screening, Sarcolipin, an inhibitor of Sarcoendoplasmic Reticulum Calcium ATPase (SERCA), emerged as essential for cell death in this context. …
-
Die Rolle der PDE3 im cGMP/cAMP-Crosstalk in NO-GC-defizienten Mäusen
… (PDE) bestimmt. Dabei spielt die PDE3 als cGMP-inhibierte, cAMP-abbauende PDE eine wichtige Rolle im sogenannten cGMP/cAMP-Crosstalk. Ein wichtiges Instrument zur Untersuchung PDE3-abhängiger Prozesse ist der spezifische Hemmstoff Milrinon. Innerhalb dieser Arbeit konnte gezeigt …
-
Compartmentation of the β-adrenergic Signal by phosphodiesterases in Adult Rat Ventricular Myocytes
… isoproterenol in the presence of cilostamide, a PDE3 inhibitor, or Ro 20-1724, a PDE4 inhibitor, on unloaded cell shortening, L-type calcium currents and intracellular calcium levels in freshly dissociated adult rat ventricular myocytes. PDE3 inhibition resulted in a 216 ± 17 % (n=8) increase in …
-
Identifying and Exploiting Metabolic Vulnerabilities to Target LKB1-Mutant Cancers
… (PDE) expressions. Particularly, LKB1 represses PDE3 through the activation of downstream salt-inducible kinase (SIK). Furthermore, PDE3 modulators can selectively target LKB1-deficient tumor cells, in contrast to those with intact LKB1. In addition, we identify resistance in some LKB1-deficient …
-
Targets of cyclic GMP in Blood Platelets: Photolabelling, mutagenesis and pharmacological analysis of the cyclic GMP-inhibited phosphodiesterase
… the cGMP-inhibited phosphodiesterase family (PDE3) (Maurice and Haslam, 1990a), an additional objective was to explore the molecular basis of the unique properties of this enzyme by cloning and mutagenesis studies. A photolabelling technique using [³²P]cGMP was modified to permit the rapid …
-
The Effect of Phosphodiesterase Inhibitors on the Induction of Gene Expression by Long-Acting beta2-Adrenoceptor Agonists and Glucocorticoids
… PDE4 inhibitors. One of these is the use of dual PDE3/4 inhibitors, which in addition to providing superior anti-inflammatory activity when compared to a PDE4 inhibitor alone, will also promote bronchodilatation. The present study demonstrates that a PDE3 plus a PDE4 inhibitor successfully …
-
cAMP signalling and phosphodiesterase activity in cystogenesis of autosomal dominant polycystic kidney disease
… that in vitro inhibition of Phosphodiesterase 3 (PDE3), an enzyme which breaks down cAMP at the plasma membrane, ER, and Outer Mitochondrial Membrane, leads to mitigated cyst formation in vitro. PDE3 inhibition also decreased ER-mitochondrial contact sites in a renal cell line. The findings are …
-
The role of phosphodiesterase 3, phosphodiesterase 5, and the inhibitory y subunit of the retinal cyclic GMP phosphodiesterase, in pulmonary hypertension
… cGMP-inhibited. cAMP specific phosphodiesterase (PDE3), and cGMP binding, cGMP specific phosphodiesterase (PDE5) activities in selected branches of the pulmonary artery (MacLean et al., 1997). The objective of this study was to establish the molecular basis for these changes in both animal and …
-
Protein Kinase A, Exchange Protein Activated By cAMP 1, and Phosphodiesterase 4D All Associate With VE-Cadherin to Regulate Endothelial Barrier Function
… aortic VEC (HAEC) permeability and PDE4 and PDE3 inhibitors decreased human microvascular VEC (HMVEC) permeability. Consistent with a role for both protein kinase A (PKA) and exchange protein activated by cAMP (EPAC) in regulating VEC permeability, selective activators of these enzymes …
-
Local cAMP signalling and phosphodiesterase activity in an in vitro model of cardiac hypertrophy
… different families of PDEs. In particular, PDE2, PDE3 and PDE4 appear to control the pool of cAMP generated in the PKA-RI compartment, whereas only PDE2 and PDE4 were found to modulate cAMP in the PKA-RII compartment in ARVM. In the in vitro cardiac hypertrophy model, a reduction in cAMP …
-
Einfluss der NO-sensitiven Guanylyl-Cyclase auf den cGMP/cAMP-Crosstalk und die Steifigkeit der murinen Aorta
… ab und beenden dadurch die Signalkaskaden. Die PDE3 spielt hierbei eine besondere Rolle, da sie eine gemischte Substratspezifität besitzt. Um den Einfluss der NO-GC auf das kardiovaskuläre System zu untersuchen, wurden NO-GC Knockout(KO)-Mäuse mit globaler (GCKO) oder Glattmuskel-spezifischer …
-
The Regulation of Brown Adipose Tissue Activation by Multiple Phosphodiesterases
… In the basal state, it required a combination of PDE3 and PDE4 inhibitors to fully induce UCP1 mRNA expression and activate lipolysis in brown adipocytes, whereas neither inhibitor had any substantial effect when administered alone. Furthermore, when injected into mice, the combination of PDE3 and …
-
Phosphodiesterasen
… und Interleukin 2-Sekretion durch Hemmung der PDE3 bzw. PDE4 zeigen, in Atemwegsepithelzellen wurde die GM-CSF-Sekretion durch PDE-Hemmer (PDE3>PDE4) supprimiert. Erstmals konnte in T-Lymphozyten die PDE7 nachgewiesen werden. Die Hemmung der PDE2 reduzierte an isolierten Lungen die Ödembildung …
-
Deciphering maturation and β-adrenergic dynamics in HiPSC-derived cardiomyocytes via integrated transcriptomic and functional profiling
… in relation to changes in activity of PDE3 and PDE4 observed using FRET-based cAMP sensors.</p> <p>This work found that the proportion of proliferative CMs was reduced with maturation. Transcriptomics showed a high proximity between hiPSC-CM groups, while functional analysis revealed …
-
Studies on cyclic AMP phosphodiesterases
… of PDEl, PDE2 and PDE7 enzymes were present, PDE3 and PDE4 enzymes were shown to provide the major Jurkat T-cell PDE activity. Chronic elevation of inti'acellular cAMP levels achieved either by direct stimulation of adenylate cyclase or via stimulation of Gs or using a cell-permanent cAMP …
-
The Role of Phosphodiesterases in Cyclic Nucleotide Compartmentation Across Different Pathways in the Adult Rat Ventricular Myocyte
… of either cilostamide (1 µM) a selective PDE3 inhibitor, or Ro 20-1724 (10 µM) a selective PDE4 inhibitor. In myocytes treated with PGE2, unloaded cell shortening and intracellular calcium transients exhibited significantly different (p<0.05) values of 147 ± 10% and 138 ± 5% of …
-
The differential regulation of cyclic AMP phosphodiesterases in T lymphocytes
… PDEl activity or cyclic GMP-inhibited, PDE3 activity was found to be present in murine thymocytes. The non-selective PDE inhibitor IBMX elicited >98% inhibition of PDE activity in thymocytes indicating the absence of IBMX- insensitive, PDE7 activity in these cells. FPLC analysis …
-
Επίδραση της σιλοσταζόλης στην έκφραση της IL-17, σε μοντέλο περιφερικής ισχαιμίας διαγονιδιακών μυών C57BL/6 Il17atm1Bcgen/J
… αναστολέας της φωσφοδιεστεράσης τύπου 3 (PDE3) με θεραπευτική εστίαση στην αύξηση του cAMP. Η αύξηση του cAMP οδηγεί σε αύξηση της ενεργού μορφής της πρωτεϊνικής κινάσης Α (ΡΚΑ), η οποία σχετίζεται άμεσα με την αναστολή της συσσώρευσης αιμοπεταλίων και αποτρέπει την ενεργοποίηση ενός …
-
The impact of cAMP signalling on the dynamics of endothelial tubule formation
… We recently showed that EPAC1-integration into a PDE3B-based VEC cAMP signalling complex allows PDE3 inhibitors to activate PI3Kγ and promote VEC adhesion to Matrigel, an early event in tubule formation. EPAC1 integrates into a PDE4D-containing, VEcadherin-based, cAMP signalling complex that …
-
Evaluation of Contraceptive Properties of Cilostazol (A Phosphodiesterase 3A Inhibitor) in Mice
… inhibitors of the phosphodiesterase 3A (PDE3A). Unfortunately, PDE3A is also expressed in the heart and blood vessels, and inhibition of PDE3A in oocytes can produce cardiovascular side effects. We reviewed the literature on available PDE3 inhibitors and selected cilostazol (CLZ), which …
Page 1 of 2